SU617017A3 - Способ получени 2-деоксистрептаминаминогликозодов или их солей - Google Patents

Способ получени 2-деоксистрептаминаминогликозодов или их солей

Info

Publication number
SU617017A3
SU617017A3 SU752184101A SU2184101A SU617017A3 SU 617017 A3 SU617017 A3 SU 617017A3 SU 752184101 A SU752184101 A SU 752184101A SU 2184101 A SU2184101 A SU 2184101A SU 617017 A3 SU617017 A3 SU 617017A3
Authority
SU
USSR - Soviet Union
Prior art keywords
solution
formula
salts
deoxystreptamin
amineglycosides
Prior art date
Application number
SU752184101A
Other languages
English (en)
Russian (ru)
Inventor
Уильям Мур Джеймс
Original Assignee
Пфайзер Корпорейшн (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Корпорейшн (Фирма) filed Critical Пфайзер Корпорейшн (Фирма)
Application granted granted Critical
Publication of SU617017A3 publication Critical patent/SU617017A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU752184101A 1974-10-26 1975-10-24 Способ получени 2-деоксистрептаминаминогликозодов или их солей SU617017A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4641274A GB1464401A (en) 1974-10-26 1974-10-26 Aminoglycosides

Publications (1)

Publication Number Publication Date
SU617017A3 true SU617017A3 (ru) 1978-07-25

Family

ID=10441164

Family Applications (1)

Application Number Title Priority Date Filing Date
SU752184101A SU617017A3 (ru) 1974-10-26 1975-10-24 Способ получени 2-деоксистрептаминаминогликозодов или их солей

Country Status (28)

Country Link
JP (1) JPS5519237B2 (es)
AR (1) AR205593A1 (es)
AT (1) AT340051B (es)
BE (1) BE834864A (es)
BG (1) BG24821A3 (es)
CA (1) CA1039275A (es)
CH (1) CH601339A5 (es)
CS (1) CS195712B2 (es)
DD (1) DD122522A5 (es)
DE (1) DE2547738C3 (es)
DK (1) DK147075C (es)
EG (1) EG11975A (es)
ES (1) ES442051A1 (es)
FI (1) FI752951A (es)
FR (1) FR2289202A1 (es)
GB (1) GB1464401A (es)
HU (1) HU172060B (es)
IE (1) IE42452B1 (es)
IL (1) IL48263A (es)
LU (1) LU73644A1 (es)
NL (1) NL162081C (es)
NZ (1) NZ179050A (es)
PH (1) PH12782A (es)
PL (1) PL99933B1 (es)
RO (1) RO72878A (es)
SE (1) SE7511945L (es)
SU (1) SU617017A3 (es)
ZA (1) ZA756326B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860513D1 (en) * 1977-06-24 1981-04-09 Scherico Ltd Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives
JPS5488241A (en) * 1977-12-21 1979-07-13 Kyowa Hakko Kogyo Co Ltd Novel fortimicin a derivative
JPS57118475U (es) * 1981-01-14 1982-07-22

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606076A5 (es) * 1973-08-06 1978-10-13 Scherico Ltd

Also Published As

Publication number Publication date
CA1039275A (en) 1978-09-26
BG24821A3 (en) 1978-05-12
CH601339A5 (es) 1978-07-14
ZA756326B (en) 1976-09-29
IE42452B1 (en) 1980-08-13
FR2289202A1 (fr) 1976-05-28
JPS5168543A (es) 1976-06-14
NL162081C (nl) 1980-04-15
PL99933B1 (pl) 1978-08-31
EG11975A (en) 1978-06-30
RO72878B (ro) 1983-06-30
PH12782A (en) 1979-08-17
IL48263A0 (en) 1975-12-31
SE7511945L (sv) 1976-04-27
AU8598175A (en) 1976-12-09
LU73644A1 (es) 1977-05-31
AR205593A1 (es) 1976-05-14
DK147075C (da) 1984-11-05
DK147075B (da) 1984-04-02
IE42452L (en) 1976-04-26
JPS5519237B2 (es) 1980-05-24
BE834864A (fr) 1976-04-26
RO72878A (ro) 1983-07-07
DE2547738C3 (de) 1978-08-03
NZ179050A (en) 1978-03-06
ATA809575A (de) 1977-03-15
DK481175A (da) 1976-04-27
CS195712B2 (en) 1980-02-29
DD122522A5 (es) 1976-10-12
GB1464401A (en) 1977-02-16
FI752951A (es) 1976-04-27
NL162081B (nl) 1979-11-15
NL7512465A (nl) 1976-04-28
FR2289202B1 (es) 1978-11-10
DE2547738B2 (de) 1977-12-01
DE2547738A1 (de) 1976-05-06
HU172060B (hu) 1978-05-28
ES442051A1 (es) 1977-04-01
AT340051B (de) 1977-11-25
IL48263A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
Grote et al. Metabolic Products of Microorganisms. 243 Pyridazomycin, a New Antifungal Antibiotic Produced by Streptomyces Violaceoniger
GB1586905A (en) Optically active amino acid-mandelic acid complexes process for preparing such complexes and process for preparing optically active amino acids or mandelic acid
US4065615A (en) Deoxyaminoglycoside antibiotic derivatives
DE2716533C3 (de) N-Acetylierte oder -halogenacetylierte Kanamycine A und B, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2529124A1 (en) Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
SU617017A3 (ru) Способ получени 2-деоксистрептаминаминогликозодов или их солей
US4009328A (en) Aminoglycoside 66-40C, method for its manufacture, method for its use as an intermediate in the preparation of known antibiotics and novel antibacterials
US4283529A (en) 3-O-Demethyl derivatives of Sannamycin C and antibiotic AX-127B-1
US4216308A (en) Fortimicin factors D and KE compounds
US3939143A (en) 1-N-isoserylkanamycins and the production thereof
Yasuzawa et al. CV-1, a new antibiotic produced by a strain of Streptomyces sp. II. structure determination
US4230848A (en) Process for producing 3-O-demethylfortimicins
Wakamiya et al. Chemical studies on tuberactinomycin. V. Structures of guanidino amino acids in tuberactinomycins
EP0517345B1 (en) Intermediates of the mureidomycin group, their preparation, and their use
US4169939A (en) Processes for the production of 3',4'-dideoxykanamycin b
US3780019A (en) Production of erythromycylamine compounds
Kullnig et al. Identification of 2-hydroxyputrescine in a pseudomonad lacking spermidine
GB2048855A (en) Istamycins
US4290972A (en) Process for the production of 4-aminobutyric acid or its derivatives
IGARASHI et al. TRUCTURE ELUCIDATION OF AN INTERMEDIATE OF 2-DEOXYSTREPTAMINE BIOSYNTHESIS
US4207415A (en) Method of producing 2-deoxyfortimicin A
US4209612A (en) Fortimicin factors KF and KG and process for production thereof
Aoyagi et al. Isolation and Identification of Saccharopine from Lentinus edodes
JP4260941B2 (ja) アゼチジン−３−オール
CA1081693A (en) Kanamycin c derivatives